Kim Champion

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha et al. · Nature Medicine · 2019 · 644 citations · Full text

Life Sciences, Immunology, Pediatrics +16

Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia

Paul Sinclair, Elisabeth P. Nacheva, M. Leversha et al. · Blood · 2000 · 309 citations

Life Sciences, Genetics, Molecular Genetics +10

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

André Tichelli, Hubert Schrezenmeier, Gèrard Socié et al. · Blood · 2011 · 213 citations · Full text

Medicine, Clinical Sciences, Hematology +15

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes

Kim Champion, James Gilbert, Fotios Asimakopoulos et al. · British Journal of Haematology · 1997 · 173 citations

Medicine, Hematology, Pathology +17

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia

Claudia Rössig, Martin Pulé, Bianca Altvater et al. · Leukemia · 2017 · 80 citations

Medicine, Immunology, Oncology +14